Atlas Trials

PCSK 9 Inhibition as Secondary Prevention in Renal Transplant Patients

Clinical trial NCT04665830 · COMPLETED

Trial details

NCT number
NCT04665830
Sponsor
Hamid Al-Essa Organ Transplant Center
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Kideny Transplant Recipients With High Cardiovascular Risk Score
Start date
2018-05-01
Primary completion
2020-05-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.